Therapeutical method for treating chronic arteriosclerosis oblit

Details Therapeutical method for treating chronic arteriosclerosis oblit Therapeutical method for treating chronic arteriosclerosis oblit

1996-09-16

1998-09-22

Henley, III, Raymond

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Ester doai

A61K 31225

Patent

active

058114572

ABSTRACT:
A therapeutical method for treating chronic arteriosclerosis obliterans in particularly selected patients with severely disabling intermittent claudication is disclosed, which comprises administering propionyl L-carnitine or a pharmacologically acceptable salts thereof.

REFERENCES:
patent: 4343816 (1982-08-01), Cavazza
patent: 4968719 (1990-11-01), Brevetti
Dialog On-line Print of Sigma-Tau Research and Development (R&D) update, 1991.

Affiliated with

Also associated with

Rating

Therapeutical method for treating chronic arteriosclerosis oblit does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutical method for treating chronic arteriosclerosis oblit, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutical method for treating chronic arteriosclerosis oblit will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1622175